Ostronic Francis Patrick 4
4 · Cyclo Therapeutics, Inc. · Filed Oct 23, 2023
Insider Transaction Report
Form 4
Ostronic Francis Patrick
Director
Transactions
- Purchase
Warrant to Purchase Common Stock
2023-10-20+65,869→ 65,869 totalExercise: $0.95From: 2023-10-20Exp: 2027-10-20→ Common Stock (65,869 underlying) - Exercise of In-Money
Warrant to Purchase Common Stock
2023-10-20$0.13/sh−59,881$7,485→ 0 totalExercise: $0.71From: 2023-04-20Exp: 2030-04-20→ Common Stock (59,881 underlying) - Exercise of In-Money
Common Stock
2023-10-20$0.71/sh+59,881$42,516→ 308,952 total
Footnotes (1)
- [F1]The Reporting Person exercised vested Warrants (the "Original Warrants") to purchase 59,881 shares of the Issuer's common stock pursuant to a Securities Purchase Agreement dated October 20, 2023 ("Closing Date"). The Reporting Person exercised his Original Warrant in full on or prior to the Closing Date in consideration of the receipt of new warrants with an exercise price equal to $0.95 per share, to purchase 110% of the shares of the Issuer's common stock covered under the Original Warrants.